EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Immunotherapy-Induced Type 1 Diabetes

Veronica Brady

Critical Care Nursing Clinics of North America · 2025

DOI: 10.1016/j.cnc.2024.07.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Critical Care Nursing Clinics of North America, 2025. Verfasst von Veronica Brady. Beteiligte Einrichtung: Department of Research, University of Texas Health- Cizik School of Nursing, 6901 Bertner Avenue, Suite 567E, Houston, TX, USA; The University of Tex…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Immunotherapy, Insulin, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Japan Association for Diabetes Education and Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the life-threatening adverse effects associated with the use of immune checkpoint inhibitors is β cells destruction resulting in type 1 diabetes. Immune checkpoint inhibitor-induced type 1 diabetes (ICI-T1D) usually has a rapid onset requiring admission to the intensive care unit for the management of diabetic ketoacidosis using an insulin drip protocol. Once stabilized patients with ICI-T1D are started on insulin therapy to mimic usual pancreatic function. Insulin administration may be through multiple daily injections or continuous subcutaneous insulin infusions using an insulin pump. People who develop ICI-T1D will require insulin therapy for life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1ImmunotherapyInsulinImmune Checkpoint InhibitorsHumansHypoglycemic AgentsDiabetic Ketoacidosis

Stichwörter der Autor:innen

Checkpoint inhibitorsDiabetic ketoacidosisHyperglycemiaImmunotherapyInsulinType 1 diabetes

Substanzen

InsulinImmune Checkpoint InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Research, University of Texas Health- Cizik School of Nursing, 6901 Bertner Avenue, Suite 567E, Houston, TX, USA; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 770…

Förderung

  • Japan Association for Diabetes Education and Care

Zitieren

APA

Brady, V. (2025). Management of Immunotherapy-Induced Type 1 Diabetes. Critical Care Nursing Clinics of North America. https://doi.org/10.1016/j.cnc.2024.07.002

Vancouver

Brady V. Management of Immunotherapy-Induced Type 1 Diabetes. Critical Care Nursing Clinics of North America. 2025. doi:10.1016/j.cnc.2024.07.002

BibTeX
@article{Brady2025,
  author = {Brady, Veronica},
  title = {Management of Immunotherapy-Induced Type 1 Diabetes},
  journal = {Critical Care Nursing Clinics of North America},
  year = {2025},
  doi = {10.1016/j.cnc.2024.07.002}
}
Kostenlos starten →